The Laboratory of JBA is funded by a competitive grant from the Novo Nordisk Foundation (#14040). PMG, CJO, JFLB were awarded postdoc fellowships from the European Union Marie Curie program – MiRCHOL, EpiTarget and EpiCC, respectively. PMG was awarded a Sheila Sherlock postdoc fellowship from the European Association for the Study of the Liver (EASL). AT was awarded an individual postdoc fellowship from the Lundbeck Foundation. LD was awarded a PhD project grant from the Danish Cancer Research Foundation. This project was supported by the European Union’s Horizon 2020 research and innovation program under the Marie Skłodowska-Curie grant agreement no. 801481. JMB is supported by Spanish Carlos III Health Institute (ISCIII) [(FIS PI18/01075, PI21/ 00922, and Miguel Servet Programme CPII19/00008) cofinanced by “Fondo Europeo de Desarrollo Regional” (FEDER)] and CIBERehd (ISCIII); La Caixa Scientific Foundation (HR17-00601); AMMF-The Cholangiocarcinoma Charity (EU/ 2019/AMMFt/001); PSC Partners US and PSC Supports UK (06119JB); European Union’s Horizon 2020 Research and Innovation Program [grant number 825510, ESCALON]. MSM is supported by the National Science Foundation (SNSF; Grant No. 320030_189275)


Project title
The Laboratory of JBA is funded by a competitive grant from the Novo Nordisk Foundation (#14040). PMG, CJO, JFLB were awarded postdoc fellowships from the European Union Marie Curie program – MiRCHOL, EpiTarget and EpiCC, respectively. PMG was awarded a Sheila Sherlock postdoc fellowship from the European Association for the Study of the Liver (EASL). AT was awarded an individual postdoc fellowship from the Lundbeck Foundation. LD was awarded a PhD project grant from the Danish Cancer Research Foundation. This project was supported by the European Union’s Horizon 2020 research and innovation program under the Marie Skłodowska-Curie grant agreement no. 801481. JMB is supported by Spanish Carlos III Health Institute (ISCIII) [(FIS PI18/01075, PI21/ 00922, and Miguel Servet Programme CPII19/00008) cofinanced by “Fondo Europeo de Desarrollo Regional” (FEDER)] and CIBERehd (ISCIII); La Caixa Scientific Foundation (HR17-00601); AMMF-The Cholangiocarcinoma Charity (EU/ 2019/AMMFt/001); PSC Partners US and PSC Supports UK (06119JB); European Union’s Horizon 2020 Research and Innovation Program [grant number 825510, ESCALON]. MSM is supported by the National Science Foundation (SNSF; Grant No. 320030_189275)

Publications
(All)

Results 1-1 of 1 (Search time: 0.002 seconds).

Issue DateTitleAuthor(s)TypeAccess
1Feb-2023MicroRNA-27a-3p targets FoxO signalling to induce tumour-like phenotypes in bile duct cellsDuwe, Lea; Munoz-Garrido, Patricia; Lewinska, Monika; Lafuente-Barquero, Juan; Satriano, Letizia; Høgdall, Dan; Taranta, Andrzej; Nielsen, Boye S.; Ghazal, Awaisa; Matter, Matthias S.; Banales, Jesus M.; Aldana, Blanca I.; Gao, Yu-Tang; Marquardt, Jens U.; Roberts, Lewis R.; Oliveira, Rui C. ; Koshiol, Jill; O'Rourke, Colm J.; Andersen, Jesper B.articleopenAccess